Alexion Pharmaceuticals, Inc.
ALXNDelisted Jul 21, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000899866
Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.
Holders of 5% or more of ALXN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alexion Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Alexion Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Alexion Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
No Schedule 13D or 13G filings on Alexion Pharmaceuticals, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Alexion Pharmaceuticals, Inc. shares.
No Form 144 notices for Alexion Pharmaceuticals, Inc. are on file.